Which one of the following first line drug used to manage post-resuscitation hypotension?

NORCET 3 - 2022 (Shift-2)

Pharmacology

Easy

Appeared in: NORCET 3 - 2022 (Shift-2)

Explanation

Norepinephrine (NORAD) is the recommended first-line vasopressor for managing hypotension after the return of spontaneous circulation (ROSC).
Its primary mechanism is potent alpha-adrenergic stimulation, which causes widespread vasoconstriction, increases systemic vascular resistance (SVR), and raises mean arterial pressure (MAP).
Compared to other vasopressors like dopamine, norepinephrine has a lower risk of causing tachyarrhythmias, making it a safer and more effective choice in this critical setting.
Guidelines from major resuscitation councils prioritize norepinephrine for post-cardiac arrest care to ensure adequate cerebral and coronary perfusion.

Option A: Adrenaline (Epinephrine) is generally considered a second-line agent for post-ROSC hypotension. While it is a potent vasopressor, it has stronger beta-1 adrenergic effects, leading to a higher risk of tachycardia and myocardial ischemia, which can be detrimental after a cardiac arrest.
Option C: Dopamine is no longer recommended as a first-line treatment for post-ROSC hypotension. Studies have shown it is associated with a higher rate of arrhythmias, including tachycardia, compared to norepinephrine, without offering superior benefit.
Option D: While IV fluid is a critical initial intervention to correct potential hypovolemia, it is not the first-line drug for persistent vasodilation-induced hypotension. The question specifically asks for a drug, implying a pharmacological agent like a vasopressor. Fluids address volume, while vasopressors address vascular tone.

Visual 1: Flowchart: Management of Post-ROSC Hypotension. This visual would show the algorithm starting with an assessment of blood pressure, followed by an IV fluid challenge, and then the initiation of a norepinephrine infusion if hypotension persists, including target MAP goals.
Visual 2: Table: Comparison of Vasoactive Drugs. A table comparing Norepinephrine, Epinephrine, and Dopamine based on their receptor activity (alpha, beta), primary effects (vasoconstriction, inotropy), and key clinical considerations (arrhythmia risk).

Clinical Relevance

Nursing practice connection: Knowing First-line drug for post-resuscitation hypotension helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Maintaining adequate blood pressure (MAP greater than 65 mmHg) after ROSC is critical to ensure perfusion to the brain and heart, preventing secondary injury from ischemia.
Nurses in critical care settings are responsible for the safe administration and titration of vasopressor infusions, requiring continuous hemodynamic monitoring and vigilance for complications like extravasation.
What if? If the patient's hypotension is accompanied by signs of cardiogenic shock (e.g., low cardiac index on monitoring, cold extremities despite adequate MAP), an inotrope like dobutamine might be added to the norepinephrine infusion to improve cardiac contractility.

How to Approach the Question

First, identify the key clinical scenario: 'post-resuscitation hypotension'. This points to the specific guidelines for post-cardiac arrest care.
Next, focus on the specific question: 'first line drug'. This requires you to differentiate between initial actions (like giving fluids) and the preferred pharmacological agent.
Analyze the options. Recognize that ADR, NORAD, and Dopamine are all vasopressors, while IV Fluid is a volume expander.
Recall or deduce the current ACLS (Advanced Cardiac Life Support) guidelines. These guidelines recommend norepinephrine as the primary vasopressor due to its effectiveness and better safety profile (fewer arrhythmias) compared to dopamine.
Eliminate the other options based on this knowledge: IV fluid is an initial step but not the first-line drug for persistent hypotension, and both Adrenaline and Dopamine are considered second-line or alternative agents.

Concept Tested & Keywords

Q0aXGB8DHZvVPH9aclO6OA